National HealthCare Corporation (NHC)

NYSEAMERICAN: NHC · USD

$211

-0.34 (-0.2%)· Recorded snapshot

Market cap	3.3B
Revenue (ttm)	1.6B
Net income (ttm)	140.3M
EPS (ttm)	$8.90
Shares out	15.7M
P/E (trailing)	23.8x
Dividend	$2.68 (1.27%)
Volume	240,216
Beta	0.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.6B
Net income (ttm): 140.3M
EPS (ttm): $8.90
P/E (trailing): 23.8x
Market cap: 3.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E23.8

P25 n/aP50 n/aP75 n/a

ROE13.3

P25 n/aP50 n/aP75 n/a

ROIC12.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NHC indicators

Market & fundamental data

Available fields

283

Groups with data

Currency

USD

Showing 283 of 283 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001047335
Company name	National HealthCare Corporation
Country	United States
Country code	US
CUSIP number	635906100
Earnings date	2026-11-10
Earnings time	bmo
Employees	15,278
Employees change	316
Employees growth	2.11%
Enterprise value	$3.1B
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1971
In index	RUSSELL2000
Industry	Medical Care Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US6359061008
Last 10-K release date	2026-02-26
Last earnings date	2026-08-07
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.3B
Market cap category	Mid-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$211.48
Price currency	USD
Sector	Healthcare
SIC code	8051
Stock price date	2026-10-28
Symbol	NHC
U.S. state	Tennessee
Website	https://www.nhccare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	21.46x
Average P/E ratio (3Y)	18.34x
Average P/E ratio (5Y)	21.32x
Earnings yield	4.21%
EV/Earnings	22.89x
EV/EBIT	22.2x
EV/EBITDA	16.87x
EV/FCF	21.91x
EV/Sales	2.06x
FCF / EV yield	4.56%
FCF yield	4.32%
Graham number	119.79703
Graham upside	-44.66%
Industry forward P/E	14.81x
Industry P/E	18.21x
Lynch fair value	$44.50
Lynch upside	-79.44%
P/(FCF - SBC) ratio	24.02x
P/(OCF - SBC) ratio	18.48x
P/B ratio	2.96x
P/E ratio	23.76x
P/FCF ratio	23.14x
P/OCF ratio	17.96x
P/S ratio	2.17x
Price / tangible book value	3.64x
Price/EBITDA ratio	17.81x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.28%
EBITDA margin	12.21%
Effective tax rate	22.94%
FCF margin	9.4%
Gross margin	39.49%
Operating margin	9.28%
Pretax margin	11.89%
Profit margin	9%
Profit per employee	$9,181
Profitable quarters	15
Profitable years	27
Revenue per employee	$102,043
ROA	5.84%
ROA (5Y)	2.39%
ROCE	11.12%
ROE	13.27%
ROE (5Y)	9.71%
ROIC	12.21%
ROIC (5Y)	4.59%
SBC / revenue	0.35%
Tax / revenue	2.73%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	32.85%
EPS growth (Q)	67.11%
EPS growth (QoQ)	11.89%
EPS growth 10Y	10.11%
EPS growth 3Y	62.5%
EPS growth 5Y	-3.82%
EPS growth quarters	3
EPS growth years	3
FCF growth	23.22%
FCF growth (Q)	-41.57%
FCF growth (QoQ)	-41.88%
FCF growth 3Y	57.96%
FCF growth 5Y	17.24%
Gross profit growth	10.77%
Gross profit growth (Q)	11.96%
Gross profit growth 3Y	15.13%
Gross profit growth 5Y	11.43%
Net income growth	33.84%
Net income growth (Q)	69.97%
Net income growth (QoQ)	12.44%
Net income growth 3Y	63.78%
Net income growth 5Y	-3.38%
Net income growth quarters	3
Net income growth years	3
OCF growth	26.66%
OCF growth (Q)	-31.12%
OCF growth (QoQ)	-30.81%
OCF growth 10Y	7.74%
OCF growth 3Y	44.07%
OCF growth 5Y	16.32%
Operating income growth	24.13%
Operating income growth (Q)	43.55%
Operating income growth 3Y	63.16%
Operating income growth 5Y	33.62%
Revenue growth	6.92%
Revenue growth (Q)	8.83%
Revenue growth (QoQ)	6.86%
Revenue growth 10Y	5.45%
Revenue growth 3Y	12.77%
Revenue growth 5Y	10.16%
Revenue growth quarters	13
Revenue growth years	13

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-42.3M
Depreciation and amortization	$45.7M
EBIT	$144.7M
EBITDA	$190.4M
EPS	$8.90
FCF per share	$9.36
Financing cash flow	$-154.4M
Free cash flow	$146.5M
Free cash flow minus SBC	$141.1M
Gross profit	$615.6M
Income taxes	$42.5M
Investing cash flow	$-112.5M
Net borrowing	$-110M
Net cash flow	$-78.1M
Net income	$140.3M
Operating cash flow minus SBC	$183.4M
Operating income	$144.7M
Revenue	$1.6B
Stock-based compensation	$5.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.56
Book value per share	$71.66
Debt / EBITDA	0.13
Debt / equity	0.03
Debt / FCF	0.21
Goodwill	$170.5M
Interest coverage	56.65
Long-term assets	$1.1B
Long-term liabilities	$172.8M
Net cash (debt)	$178.8M
Net cash / market cap	5.27%
Net cash growth	110.29%
Net debt / EBITDA	-0.94
Net debt / equity	-0.16
Net debt / FCF	-1.22
Piotroski F-Score	7
Property, plant and equipment	$758.4M
Shareholders' equity	$1.1B
Tangible book value	$931.5M
Tangible book value per share	$59.47
Total assets	$1.5B
Total cash	$210.2M
Total debt	$31.4M
Total liabilities	$408.9M
WACC	7.61%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.01
Current assets	$439.6M
Current liabilities	$236.1M
Current ratio	1.86
Inventory turnover	114.85
Net working capital	$11.6M
Quick ratio	1.47
Working capital	$203.5M
Working capital turnover	7.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.86%
Dividend growth	4.8%
Dividend growth (10Y)	4.42%
Dividend growth (3Y)	4.14%
Dividend growth (5Y)	4.72%
Dividend growth years	21
Dividend payment date	2026-10-30
Dividend payment years	23
Dividend payout frequency	Quarterly
Dividend per share	$2.68
Dividend yield	1.27%
Ex-dividend date	2026-09-30
FCF payout ratio	28.64%
Last dividend	$0.67
Payout ratio	30.11%
Shareholder yield	0.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	227.36%
10Y return CAGR	15.72%
10Y total return	330.48%
150-day SMA	$205.81
15Y price change	434.41%
15Y return CAGR	15.01%
15Y total return	715.04%
1D price change	-0.16%
1M price change	-6.76%
1M total return	-6.48%
1W price change	-14.5%
1W total return	-14.5%
1Y price change	76.11%
1Y return CAGR	78.81%
1Y total return	78.74%
20-day SMA	$230.83
200-day SMA	$193.35
20Y price change	282.6%
20Y return CAGR	9.85%
20Y total return	554.26%
3M price change	-6.23%
3M total return	-5.95%
3Y price change	220.73%
3Y return CAGR	50.51%
3Y total return	241.03%
50-day SMA	$227.02
50-day SMA vs 200-day SMA	50over200
52-week high	$248.20
52-week high date	2026-10-21
52-week low	$118.14
52-week low date	2025-11-03
5Y price change	218.41%
5Y return CAGR	29.44%
5Y total return	263.29%
6M price change	20.2%
6M total return	20.95%
All-time high	$248.20
All-time high date	2026-10-21
All-time low	$2.25
All-time low date	2000-10-18
Average true range (ATR)	$8.41
Average volume	124.2K
Beta (1Y)	-0.44
Beta (2Y)	0.36
Beta (5Y)	0.61
Change from 52-week high	-14.79%
Change from 52-week low	79.01%
Change from all-time high	-14.59%
Change from all-time low	9,322.22%
Change from open	-0.13%
Day's gap	-0.02%
Dollar volume	$50.8M
High price	$217.01
Low price	$210.83
Monthly RSI	73.9
Open price	$211.76
Position in 52-week range	10.52%
Previous close	$211.81
Price vs 150-day SMA	3.01%
Price vs 20-day SMA	-8.16%
Price vs 200-day SMA	9.64%
Price vs 50-day SMA	-6.62%
Relative volume	1.93
RSI	38.14
Sharpe ratio	1.73
Sharpe ratio (3Y)	1.35
Sharpe ratio (5Y)	0.86
Sortino ratio	2.97
Sortino ratio (3Y)	2.34
Sortino ratio (5Y)	1.54
Volume	240.2K
Weekly RSI	51.29
YTD price change	54.64%
YTD total return	56.23%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12.7M
Float percentage	81.18%
Shares change (QoQ)	0.59%
Shares change (YoY)	0.86%
Shares held by insiders	12.21%
Shares held by institutions	66.82%
Shares outstanding	15.7M
Short % of float	6.43%
Short % of shares	5.22%
Short ratio	7.6 days

Deeper analysis on NHC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NHC report

Is a complete NHC research report available?

No complete published report is available for National HealthCare Corporation (NHC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

National HealthCare Corporation (NHC)

Price

Financial snapshot

Fair-value bridge

Latest news · NHC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NHC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NHC

Frequently asked questions